相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Optimal phosphate control: still an unmet need in chronic kidney disease patients
Francesco Locatelli et al.
EXPERT OPINION ON PHARMACOTHERAPY (2014)
Sevelamer Versus Calcium Carbonate in Incident Hemodialysis Patients: Results of an Open-Label 24-Month Randomized Clinical Trial
Biagio Di Iorio et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2013)
Lanthanum Carbonate Delays Progression of Coronary Artery Calcification Compared With Calcium-Based Phosphate Binders in Patients on Hemodialysis: A Pilot Study
Takayasu Ohtake et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2013)
Cardiac valve calcification: an immutable pathologic finding in chronic kidney disease?
Antonio Bellasi et al.
JOURNAL OF NEPHROLOGY (2013)
Use of phosphate-binding agents is associated with a lower risk of mortality
Jorge B. Cannata-Andia et al.
KIDNEY INTERNATIONAL (2013)
Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease
Kathleen M. Hill et al.
KIDNEY INTERNATIONAL (2013)
Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis
Sophie A. Jamal et al.
LANCET (2013)
A comparison of calcium acetate/magnesium carbonate and sevelamer-hydrochloride effects on fibroblast growth factor-23 and bone markers: post hoc evaluation from a controlled, randomized study
Adrian Covic et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Evaluation of colestilan in chronic kidney disease dialysis patients with hyperphosphataemia and dyslipidaemia: a randomized, placebo-controlled, multiple fixed-dose trial
Francesco Locatelli et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Efficacy and safety of lanthanum carbonate on chronic kidney disease-mineral and bone disorder in dialysis patients: a systematic review
Chenglong Zhang et al.
BMC NEPHROLOGY (2013)
Management of hyperphosphataemia in chronic kidney disease-challenges and solutions
Markus Ketteler et al.
CLINICAL KIDNEY JOURNAL (2013)
Phosphate Binder Use and Mortality Among Hemodialysis Patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS): Evaluation of Possible Confounding by Nutritional Status
Antonio Alberto Lopes et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2012)
Mortality in Kidney Disease Patients Treated with Phosphate Binders: A Randomized Study
Biagio Di Iorio et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Sevelamer for hyperphosphataemia in kidney failure: controversy and perspective
Mario Cozzolino et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2012)
Comparative Effectiveness of Calcium-Containing Phosphate Binders in Incident US Dialysis Patients
Wolfgang C. Winkelmayer et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Prognostic Value of Aortic Stiffness and Calcification for Cardiovascular Events and Mortality in Dialysis Patients: Outcome of the Calcification Outcome in Renal Disease (CORD) Study
Francis Verbeke et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Pharmacology, efficacy and safety of oral phosphate binders
Alastair J. Hutchison et al.
NATURE REVIEWS NEPHROLOGY (2011)
Attenuation of aortic calcification with lanthanum carbonate versus calcium-based phosphate binders in haemodialysis: A pilot randomized controlled trial
Nigel D. Toussaint et al.
NEPHROLOGY (2011)
Absorption of Levothyroxine When Coadministered with Various Calcium Formulations
Isabelle Zamfirescu et al.
THYROID (2011)
Do aluminium-based phosphate binders continue to have a role in contemporary nephrology practice?
David W. Mudge et al.
BMC NEPHROLOGY (2011)
Contribution of Intestine, Bone, Kidney, and Dialysis to Extracellular Fluid Calcium Content
David A. Bushinsky
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Understanding Sources of Dietary Phosphorus in the Treatment of Patients with Chronic Kidney Disease
Kamyar Kalantar-Zadeh et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability
Angel L. M. de Francisco et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Drug Therapy: Oral Phosphate Binders in Patients with Kidney Failure.
Marcello Tonelli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Assessment of survival in a 2-year comparative study of lanthanum carbonate versus standard therapy
R. Wilson et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Long-term effects of magnesium carbonate on coronary artery calcification and bone mineral density in hemodialysis patients: A pilot study
David M. Spiegel et al.
HEMODIALYSIS INTERNATIONAL (2009)
Phosphorus Binders and Survival on Hemodialysis
Tamara Isakova et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
The emerging role of phosphate in vascular calcification
Cecilia M. Giachelli
KIDNEY INTERNATIONAL (2009)
Efficacy and safety of sevelamer hydrochloride and calcium acetate in patients on peritoneal dialysis
Pieter Evenepoel et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Clinical Implications of Disordered Magnesium Homeostasis in Chronic Renal Failure and Dialysis
Juan F. Navarro-Gonzalez et al.
SEMINARS IN DIALYSIS (2009)
Colesevelam Hydrochloride and Lanthanum Carbonate Interfere with the Absorption of Levothyroxine
Steven P. Weitzman et al.
THYROID (2009)
A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: The calcium acetate renagel evaluation-2 (CARE-2) study
Wajeh Qunibi et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2008)
A model of the kinetics of lanthanum in human bone, using data collected during the clinical development of the phosphate binder lanthanum carbonate
Felix Bronner et al.
CLINICAL PHARMACOKINETICS (2008)
Clinical pharmacokinetics of the phosphate binder lanthanum carbonate
Stephen J. P. Damment et al.
CLINICAL PHARMACOKINETICS (2008)
Magnesium carbonate for phosphate control in patients on hemodialysis. A randomized controlled trial
Ioannis P. Tzanakis et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2008)
The mechanism of phosphorus as a cardiovascular risk factor in CKD
Suresh Mathew et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Phosphate Binder Impact on Bone Remodeling and Coronary Calcification - Results from the BRiC Study
Daniela Veit Barreto et al.
NEPHRON CLINICAL PRACTICE (2008)
Long-term efficacy and safety profile of lanthanum carbonate: Results for up to 6 years of treatment
Alastair J. Hutchison et al.
NEPHRON CLINICAL PRACTICE (2008)
Lower gastrointestinal bleeding: Association with sevelamer use
Pankaj Madan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Phosphate binders and timing of levothyroxine administration
Margret Arnadottir et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Survival in end stage renal disease: calcium carbonate vs. sevelamer
A. M. Borzecki et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2007)
Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients
W. N. Suki et al.
KIDNEY INTERNATIONAL (2007)
Effects of lanthanum carbonate on the absorption and oral bioavailability of ciprofloxacin
Priscilla P. How et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Systematic review of the clinical efficacy and safety of sevelamer in dialysis patients
Marcello Tonelli et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2007)
Relative in vitro efficacy of the phosphate binders lanthanum carbonate and sevelamer hydrochloride
Valerie Autissier et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2007)
Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients
G. A. Block et al.
KIDNEY INTERNATIONAL (2007)
Cognitive function in Stage 5 chronic kidney disease patients on hemodialysis: No adverse effects of lanthanum carbonate compared with standard phosphate-binder therapy
P. Altmann et al.
KIDNEY INTERNATIONAL (2007)
Metabolic bone disease in chronic kidney disease
Kevin J. Martin et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Emerging drugs for hyperphosphatemia
Guido Bellinghieri et al.
EXPERT OPINION ON EMERGING DRUGS (2007)
Evolution of bone and plasma concentration of lanthanum in dialysis patients before, during 1 year of treatment with lanthanum carbonate and after 2 years of follow-up
Goce B. Spasovski et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
The case against calcium-based phosphate binders
Sharon M. Moe et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: A longitudinal study
M. L. Melamed et al.
KIDNEY INTERNATIONAL (2006)
Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis
GA Block et al.
KIDNEY INTERNATIONAL (2005)
Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density
HG Asmus et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: The USRDS waves 1, 3, and 4 study
Y Slinin et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Patterns Study
EW Young et al.
KIDNEY INTERNATIONAL (2005)
The effect of sevelamer on the pharmacokinetics of cyclosporin A and mycophenolate mofetil after renal transplantation
AK Pieper et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
Effects of sevelamer hydrochloride and calcium acetate on the oral bioavailability of ciprofloxacin
MB Kays et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2003)
Arterial media calcification in end-stage renal disease:: impact on all-cause and cardiovascular mortality
GM London et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2003)
Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients
GM Chertow et al.
KIDNEY INTERNATIONAL (2002)
Cardiac calcification in adult Hemodialysis patients - A link between end-stage renal disease and cardiovascular disease?
P Raggi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Aluminium and bone disease in chronic renal failure
HH Malluche
NEPHROLOGY DIALYSIS TRANSPLANTATION (2002)
Sevelamer hydrochloride (Renagel®), a nonabsorbed phosphate-binding polymer, does not interfere with digoxin or warfarin pharmacokinetics
S Burke et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Arterial stiffening and vascular calcifications in end-stage renal disease
AP Guérin et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2000)
Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis
WG Goodman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
